Among obese and overweight patients treated with Ecnoglutide, more than 90 percent lost over 5 percent of weight, with the biggest loss at 15 percent, Ji noted
Follow a Slow Dose Increase Schedule Tirzepatide is usually started at a low dose
The average age of participants was 54 (SD = 6) years, the majority (90%) were either overweight or obese (BMI 25), and almost 40% of the sample were retired/disabled due to their illness (69)
Patients should be encouraged to maintain adequate hydration, consume nutrient-dense foods, and consider consultation with a registered dietitian
It is simple and quick to use in clinical practice and is especially helpful for stratifying biliary AP, although clinical validation remains limited
I share the pronunciations, syllable breakdowns, and more